The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...

Two former Pfizer top executives won’t participate in an activist investor’s effort to pressure the drugmaker to make changes ...

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...